Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01889 (
ankylosing spondylitis
)
5,717
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Objective:
Despite extensive studies, the precise mechanism underlying spondyloarthritis, especially
ankylosing spondylitis
, remains elusive. This study aimed to develop an ideal animal model for an insight into mechanism of spondyloarthritis and functional relevance of
SOCS3
in spondyloarthritis.
Methods:
Since
SOCS3
is a major regulator of IL23-STAT3 signaling, we generated
SOCS3
knockdown transgenic (TG) mice for development of an animal model of spondyloarthritis. A hydrodynamic delivery method was employed to deliver minicircle DNA expressing IL23 (mc-IL23) into wild-type (WT) and the TG mice. Knockdown/overexpression systems mediated by lentivirus and retrovirus were used to determine whether
SOCS3
regulated osteoblast differentiation.
Results:
Forced expression of IL23 induced severe joint destruction and extensive bone loss in
SOCS3
knockdown TG mice, while this treatment only caused moderate symptoms in WT mice. Furthermore, severe spondyloarthritis was found in IL23-injected TG mice as compared to mild disease observed in WT controls under same condition. Moreover, our studies showed that IL23 promoted osteoblast differentiation via activation of STAT3 pathway and disruption of
SOCS3
expression greatly increased phosphorylation of STAT3. In addition, silencing
SOCS3
resulted in enhanced osteoblast differentiation through activation of Smad1/5/9 signaling, as evidenced by elevated phosphorylation level of Smad1/5/9. Experiments further demonstrated that
SOCS3
interacted with Smad1 and thus suppressed the BMP2-Smad signaling.
Conclusions:
The results reveal that
SOCS3
is involved in IL23-induced spondyloarthritis and acts as a key regulator of osteoblast differentiation, and suggest that
SOCS3
knockdown TG mice may be an ideal animal model for further studies of spondyloarthritis.
...
PMID:Silencing SOCS3 Markedly Deteriorates Spondyloarthritis in Mice Induced by Minicircle DNA Expressing IL23. 3048 98